Literature DB >> 1827248

Atrial natriuretic peptide and blood volume during red cell transfusion in preterm infants.

W Rascher1, N Lingens, M Bald, O Linderkamp.   

Abstract

Because raised plasma concentrations of atrial natriuretic peptide indicate volume expansion, we studied the effect of red cell transfusion on plasma atrial natriuretic peptide concentration, packed cell volume, and intravascular volume in eight preterm infants. Red cell transfusion increased red cell mass, packed cell volume and erythrocyte count, but decreased plasma volume. Total blood volume, plasma atrial natriuretic peptide concentration, urine flow rate, and urinary sodium excretion did not change. We conclude that a slow transfusion of less than 10 ml red cells/kg body weight does not cause volume expansion with subsequent atrial natriuretic peptide release thereby affecting the cardiovascular system.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1827248      PMCID: PMC1590297          DOI: 10.1136/adc.66.4_spec_no.395

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  16 in total

1.  Relationship between plasma atrial natriuretic peptide concentrations and cardio-thoracic ratio during the early neonatal period.

Authors:  T Kojima; Y Fukuda; Y Hirata; A Ono; Y Kinoshita; S Matsuzaki; S Iwase; Y Kobayashi
Journal:  Acta Paediatr Scand       Date:  1989-01

Review 2.  Assessment of anemia in newborn infants.

Authors:  V S Blanchette; A Zipursky
Journal:  Clin Perinatol       Date:  1984-06       Impact factor: 3.430

Review 3.  Placental transfusion: determinants and effects.

Authors:  O Linderkamp
Journal:  Clin Perinatol       Date:  1982-10       Impact factor: 3.430

4.  Changes in plasma concentrations of atrial natriuretic peptide during exchange transfusion in premature infants.

Authors:  A Khoór; T Tulassay; M Bald; W Rascher
Journal:  Acta Paediatr Scand       Date:  1990-05

5.  Intraventricular hemorrhage: a prospective evaluation of etiopathogenesis.

Authors:  F D Dykes; A Lazzara; P Ahmann; B Blumenstein; J Schwartz; A W Brann
Journal:  Pediatrics       Date:  1980-07       Impact factor: 7.124

Review 6.  Anemia of prematurity. Current concepts in the issue of when to transfuse.

Authors:  J A Stockman
Journal:  Pediatr Clin North Am       Date:  1986-02       Impact factor: 3.278

7.  Atrial natriuretic factor--a circulating hormone stimulated by volume loading.

Authors:  R E Lang; H Thölken; D Ganten; F C Luft; H Ruskoaho; T Unger
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

8.  Atrial natriuretic peptide in patent ductus arteriosus.

Authors:  S Andersson; I Tikkanen; E Pesonen; O Meretoja; M Hynynen; F Fyhrquist
Journal:  Pediatr Res       Date:  1987-04       Impact factor: 3.756

9.  Atrial natriuretic peptide and extracellular volume contraction after birth.

Authors:  T Tulassay; I Seri; W Rascher
Journal:  Acta Paediatr Scand       Date:  1987-05

10.  Elevated atrial natriuretic factor in neonates with respiratory distress syndrome.

Authors:  S G Shaffer; P G Geer; K L Goetz
Journal:  J Pediatr       Date:  1986-12       Impact factor: 4.406

View more
  5 in total

Review 1.  Atrial natriuretic factor and neonatal body fluid homeostasis.

Authors:  G Karthikeyan; S Singhi
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

Review 2.  Management of fluid balance in the very immature neonate.

Authors:  N Modi
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-03       Impact factor: 5.747

3.  Atrial natriuretic peptide and blood volume during red cell transfusion in preterm infants.

Authors:  M Y Anthony; M I Levene
Journal:  Arch Dis Child       Date:  1991-09       Impact factor: 3.791

Review 4.  Guidelines for the administration of blood products.

Authors:  R Warwick; N Modi
Journal:  Arch Dis Child       Date:  1995-05       Impact factor: 3.791

5.  Haemodynamic effects of erythrocyte transfusion in preterm infants.

Authors:  Jaana A Leipälä; Talvikki Boldt; Vineta Fellman
Journal:  Eur J Pediatr       Date:  2004-04-14       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.